Cogdell Spencer Announces Chief Executive Officer Frank C. Spencer Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner in the... (es and contribute significantly to the s...)

HOME >> MEDICINE >> NEWS

Cogdell Spencer Announces Chief Executive Officer Frank C. Spencer Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner in the Carolinas

Date:6/22/2009

es and contribute significantly to the strength of our region's economy. Their success helps our area grow stronger."

As a Carolinas award winner, Mr. Spencer is now eligible for consideration for the Ernst & Young LLP Entrepreneur Of The Year 2009 national program. Award winners in several national categories, as well as the overall national Ernst & Young Entrepreneur Of The Year award winner, will be announced at the annual awards gala in Palm Springs, California on November 14, 2009. The awards are the culminating event of the Ernst & Young Strategic Growth Forum, the nation's most prestigious gathering of high-growth, market-leading companies.

Sponsors

Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year awards are pleased to have the Ewing Marion Kauffman Foundation and SAP America as national sponsors.

In the Carolinas, local sponsors include King & Spalding, Business Leader Media and Bowne.

About Cogdell Spencer Inc.

Charlotte-based Cogdell Spencer Inc. (NYSE: CSA) is a fully-integrated, self-administered, and self-managed real estate investment trust ("REIT") that invests in specialty office buildings for the medical profession, including medical offices and ambulatory surgery and diagnostic centers. The Company focuses on the ownership, development, redevelopment, acquisition, and management of strategically located medical office buildings and other healthcare related facilities in the United States of America. The Company has been built around understanding and addressing the full range of specialized real estate needs of the healthcare industry. Learn more about Cogdell Spencer Inc. and its subsidiaries at www.cogdellspencer.com.

SOURCE Cogdell Spencer Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Industry in the U.S. and its ... ,, http://www.reportlinker.com/p0167482/In-Vitro-Diagnostic-Substance-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The ... Industry report provides the latest market ...

(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, ... - Market Forecasts to 2015, Competitive ... ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...

(Date:12/15/2009)... Aon Consulting, the global human capital consulting ... AON ), today announced Lisa Zeitel has ... with the Health & Benefits Practice and ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20041215/CGW049LOGO ) ,, ... under the direction of Aon Consulting,s Pharmacy ...

(Date:12/15/2009)... Dec. 15 Hospira, Inc. (NYSE: ... in generic injectable pharmaceuticals, and Orchid Chemicals ... a leading Indian pharmaceuticals company and among ... today announced an agreement for Hospira to ... business for approximately $400 million. ,, ...

(Date:12/15/2009)... acid synthesis in brain cancer cells may offer a ... glioblastomas that are driven by amplified signaling of the ... study by researchers at UCLA,s Jonsson Comprehensive Cancer Center. ... the formation of new membranes. The fatty acids also ... and may be important for regulating cell signaling, said ...

[0] Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition][0] Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Aon Consulting Adds Senior Vice President to National Pharmacy Practice [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business [0] Targeting brain cancer cell metabolism may provide new treatment

... Champion,SAN FRANCISCO, May 13 Brown & Toland Physicians ... award Lisa Marie Harrison of San Ramon the inaugural ... Bay Area woman who has made dramatic improvements to ... time weighed 235 pounds and smoked heavily. After a ...

... to be Implemented Across Slovenia LJUBLJANA, Slovenia, May 13 ... that it will roll out a new electronic health ... IBM ) technology across the country.(Logo: ... healthcare providers to instantly and accurately check a patient,s ...

... report suggests , , WEDNESDAY, May 13 (HealthDay News) -- ... least one bout of major depression in the past ... received treatment, a new government report released Wednesday shows. ... Services Administration (SAMHSA), the report found that health insurance ...

... that looked at obituary photographs published in one metropolitan newspaper ... appearance, particularly for women. , The study found that the ... younger age than when he or she died more than ... than twice as likely as men to have an obituary ...

... Enables Pulmonx to Develop Both Assessment Tools and ... 13 Pulmonx, a medical device company focused ... today that it has acquired all of the ... (EBV) technology platform and associated intellectual property. Pulmonx ...

... Pregnant women and newborns are at greatest risk ... done to ensure that they receive priority treatment should ... Medical Center (UPMC) and University of Pittsburgh study. The ... , raise concerns about the ability of hospitals to ...

Other Medicine News:Health News:IBM Helps Government of Slovenia to Build Smart Health Insurance System 2 Health News:IBM Helps Government of Slovenia to Build Smart Health Insurance System 3 Health News:Most Depressed Teens Don't Get Treatment 2 Health News:Obituary photos suggest growing bias against aging faces 2 Health News:Obituary photos suggest growing bias against aging faces 3 Health News:Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting 2 Health News:Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting 3 Health News:Influenza pandemic planning needed to assure adequate care for pregnant women and newborns 2

From Heart Attack Scare to Half-Marathon IBM Helps Government of Slovenia to Build Smart Health Insurance System Most Depressed Teens Don't Get Treatment Obituary photos suggest growing bias against aging faces Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting Influenza pandemic planning needed to assure adequate care for pregnant women and newborns

(Date:12/15/2009)... SAN DIEGO, Dec. 15 Safe ... to developing novel technologies that prevent the spread ... is ramping production of its comfortable, breathable, A400 ... agencies address the global shortage of N95 respirators ... manufacturing capacity in response to a rapid rise ...

(Date:12/15/2009)... ALTO, Calif., Dec. 15 Varian Medical Systems ... will report results for first quarter of fiscal year ... January 27, 2010. The news release will be ... at 2:00 p.m. PT. The news release and ... available on the company website at: www.varian.com/investor . ...

(Date:12/15/2009)... IRVINE, Calif., Dec. 15 Masimo (Nasdaq: ... and Measure-Through Motion and Low Perfusion pulse oximetry, ... Kiani has been awarded the 2009 Frost & ... North American Patient Monitoring market. According to Frost ... of Mr. Kiani,s "unprecedented ability in understanding customer ...

Breaking Medicine Technology:Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 2 Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 3 Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 4 Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call 2 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 2 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 3 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 4 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 5 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 6 Prodrug could help curb skin toxicity related to EGFR inhibiting cancer drugs 55918 1 Prodrug could help curb skin toxicity related to EGFR inhibiting cancer drugs 55918 2 Breast cancer 3A Risk increases for smokers and overweight women 55914 1 Breast cancer 3A Risk increases for smokers and overweight women 55914 2 Eatin 28not so 29 good in the neighborhood 9757 1 Eatin 28not so 29 good in the neighborhood 9757 2

[0] Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage [0] Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call [0] Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award

... Introgen Therapeutics, Inc.,(NASDAQ: INGN) and the Company's ... demonstrating a significant,correlation between abnormal p53, tumor ... patients with recurrent,squamous cell carcinoma of the ... presented today at the annual meeting of ...

... of Phase 2 Clinical Data Published at ... Meeting, CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- ... Phase II,multi-center clinical study of Amrubicin, the ... treatment of small cell lung cancer. These ...

Other Medicine Technology:Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2 Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3 Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4 Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 2 Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 3 Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 4

Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer

... leader in liquid handling, we are proud ... pipette that combines simplicity, comfort and functionality ... on the results of recent independent ergonomics ... Novus gives you the power to reach ...

... The PFA-100 In Vitro Diagnostic System aids ... It is the first commercially available in ... vivo function of platelets in primary hemostasis. ... shear conditions similar to the environment of ...

... Compact is a system that measures ... samples. This rate may be relevant ... The sedimentation rate is measured in ... typically used in high-volume settings such ...

... complete range of automatic systems for performing ... mL of blood. With the introduction of ... clinical diagnostic market a truly revolutionary testing ... limitation associated with the traditional ESR techique.,By ...

Medicine Products:

Finnpipette Novus PFA-100 System StaRRsed Compact Automatic ESR Analyzer Ves-matic 20

Cogdell Spencer Announces Chief Executive Officer Frank C. Spencer Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner in the...(es and contribute significantly to the s...),Health